Argipressin for prevention of blood loss during liver resection: a study protocol for a randomised, placebo-controlled, double-blinded trial (ARG-01)

INTRODUCTION: Liver resection carries a high risk for extensive bleeding and need for blood transfusions, which is associated with significant negative impact on outcome. In malignant disease, the most common indication for surgery, it also includes increased risk for recurrence of cancer. Argipress...

Descripción completa

Detalles Bibliográficos
Autores principales: Wisén, Ellinor, Kvarnström, Andreas, Sand-Bown, Lena, Rizell, Magnus, Pivodic, Aldina, Ricksten, Sven-Erik, Svennerholm, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Anaesthesia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450082/
https://www.ncbi.nlm.nih.gov/pubmed/37620260
http://dx.doi.org/10.1136/bmjopen-2023-073270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450082/
https://www.ncbi.nlm.nih.gov/pubmed/37620260
http://dx.doi.org/10.1136/bmjopen-2023-073270

Ejemplares similares